Virginia Tech®home

Virginia Tech Molecular Diagnostics Lab

Insert your title here

     


VIRGINIA TECH MOLECULAR DIAGNOSTICS LAB

AT THE FRALIN BIOMEDICAL RESEARCH INSTITUTE AT VTC

     

Loading player for https://video.vt.edu/media/Inside+Virginia+Tech's+COVID-19+analysis+lab/1_as9pwf4i...

220,000 Sample Results

As of September 2022, the Virginia Tech Molecular Diagnostics Lab has reported more than 220,000 test results since its launch on April 20, 2020. 

About the Virginia Tech Molecular Diagnostics Lab

The Virginia Tech Molecular Diagnostics Lab, located at the Fralin Biomedical Research Institute, launched on April 20, 2020. The Food and Drug Administration gave the university permission to deploy its novel assay to analyze COVID-19 samples in April, in response to an Emergency Use Authorization application. The lab receives samples from health department and does not collect samples directly from patients or facilities. 

Health districts in Southwest Virginia send coded and deidentified samples to the Virginia Tech lab for analysis. The samples are processed by researchers at the Fralin Biomedical Research Institute in Roanoke, Virginia using a quantitative real-time polymerase chain reaction (qRT-PCR) protocol to detect the virus’s genetic material. The labs can often provide results in 24 to 48 hours.

Scientific Director: Carla Finkielstein, Ph.D.,  Associate Professor, Fralin Biomedical Research Institute. For information about operations, please contact Hal Irvin, Ph.D.

CLIA #49D0016288

LABORATORY STAFF
 

Collaborators

Luciana Rosso, Ph.D., Virginia Tech

 

MOLECULAR DIAGNOSTICS LAB NEWS


MEDIA COVERAGE